Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Management of AL Amyloidosis

GRACE

S. Rajeeve

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

Multiple Myeloma: Initial Treatment Approaches

University of Colorado Division of Hematology

A. Hirose

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Rush University Medical Center

A. Suvannasankha

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

High-Risk Myeloma: Updates in Defining and Managing

Rush University Medical Center

J. Zonder

Diagnosing AL Amyloidosis

GRACE

S. Rajeeve

Multiple Myeloma: Disease Origins and Pathophysiology

University of Colorado Division of Hematology

A. Hirose

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Signs and Symptoms of AL Amyloidosis

GRACE

S. Rajeeve

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

Multiple Myeloma: Oncologic Emergencies and How to Manage Them

University of Colorado Division of Hematology

A. Hirose

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Susanibar-Adaniya

Multiple Myeloma: Initial Workup, Diagnosis, and Risk Assessment

University of Colorado Division of Hematology

A. Hirose